{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Gilead Sciences", "item": "https://www.patentleaderboard.com/2021/company/gilead-sciences"}, {"@type": "ListItem", "position": 4, "name": "Xiaofen Li", "item": "https://www.patentleaderboard.com/2021/inventor/fl:xi_ln:li-11"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
XL

Xiaofen Li — 4 Patents in 2021

GSGilead Sciences: 4 patents #7 of 206Top 4%
Overall (2021): #37,479 of 548,734Top 7%
4 Patents 2021

Issued Patents 2021

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11186579 Therapeutic heterocyclic compounds Mark J. Bartlett, Britton Kenneth Corkey, Kristyna M. Elbel, Rao V. Kalla, Thao Perry 2021-11-30 $447,914,000
11098027 Therapeutic heterocyclic compounds Mark J. Bartlett, Britton Kenneth Corkey, Jennifer L. Cosman, Elfatih Elzein 2021-08-24 $430,105,000
11040033 Therapeutic heterocyclic compounds Mark J. Bartlett, Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel, Elfatih Elzein +4 more 2021-06-22 $444,628,000
10988451 MCL-1 inhibitors Hang Chu, Juan A. Guerrero, Anna E. Hurtley, Tae H. Hwang, Lan Jiang +14 more 2021-04-27 $236,030,000